Girding for BMS competition, Amgen wins another plaque psoriasis nod for Otezla kdunleavy Tue, 12/21/2021 – 11:24 More: Girding for BMS competition, Amgen wins another plaque psoriasis nod for Otezla Source: fierce
read moreAbbVie, after losing Humira trade secrets case, eyes new strategy in Alvotech fight fkansteiner Tue, 12/21/2021 – 11:00 More: AbbVie, after losing Humira trade secrets case, eyes new strategy in Alvotech fight Source: fierce
read moreGlaxoSmithKline’s HIV prevention injectable Apretude threatens Gilead with FDA blessing. But will doctors use it? aliu Tue, 12/21/2021 – 10:34 More: GlaxoSmithKline’s HIV prevention injectable Apretude threatens Gilead with FDA blessing. But will doctors use it? Source: fierce
read moreAmgen to spend $100M to build new vial filling line at Dublin site: report jkeenan Tue, 12/21/2021 – 09:47 More: Amgen to spend 0M to build new vial filling line at Dublin site: report Source: fierce
read moreTurkish biotech bags $12M for targeted delivery of cancer drugs ntaylor Tue, 12/21/2021 – 09:28 More: Turkish biotech bags M for targeted delivery of cancer drugs Source: fierce
read moreWith approval, Saphnelo would be the first available treatment for systematic lupus erythematosus in Europe in over ten years. More: CHMP recommend Saphnelo for systematic lupus erythematosus Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals